Английская Википедия:Atazanavir/cobicistat

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Infobox drug

Atazanavir/cobicistat, sold under the brand name Evotaz, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS.[1][2] It contains atazanavir and cobicistat.[1][2][3] Atazanavir is an HIV protease inhibitor and cobicistat is an inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family.[1]

Atazanavir/cobicistat was approved by the Food and Drug Administration (FDA) for medical use in United States in January 2015.[4][5] It was approved for medical use in the European Union in July 2015.[2]

Medical uses

Atazanavir/cobicistat is indicated for use in combination with other antiretroviral agents for the treatment of HIV‑1 infection in people weighing at least Шаблон:Convert.[1][2]

References

Шаблон:Reflist

External links

Шаблон:Antiretroviral drug Шаблон:Portal bar


Шаблон:Antiinfective-drug-stub

  1. 1,0 1,1 1,2 1,3 Ошибка цитирования Неверный тег <ref>; для сносок Evotaz FDA label не указан текст
  2. 2,0 2,1 2,2 2,3 Ошибка цитирования Неверный тег <ref>; для сносок Evotaz EPAR не указан текст
  3. Шаблон:Cite journal
  4. Шаблон:Cite press release
  5. Шаблон:Cite web Шаблон:Cite web